NASH/MASH
Metabolic·MeSH: Non-alcoholic Fatty Liver Disease
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
Phase 2(1)
| Drug | Company |
|---|---|
| efruxifermin | Akero Therapeutics, Inc. (AKRO) |
Compare drugs
Frequently asked questions
How many drugs are in development for NASH/MASH?
BioSniper tracks 2 drugs in development for NASH/MASH across 1 company.
How many clinical trials target NASH/MASH?
There are 1 clinical trial targeting NASH/MASH tracked by BioSniper.
Deep-dive into NASH/MASH
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis